HELSINKI, April 29, 2026 /PRNewswire/ -- Bioretec Ltd Company release 29 April 2026 at 16:40 p.m. EEST

Bioretec Ltd: Notification pursuant to Chapter 9, Section 10 of the Finnish Securities Markets Act (Sp-Rahastoyhtiö)

Bioretec Ltd ("Bioretec" or the "Company") has received on 29 April 2026 the following notification in accordance with Chapter 9, Section 5 of the Finnish Securities Markets Act from Sp-Rahastoyhtiö Oy. According to the notification, the holding of Säästöpankki Pienyhtiöt, an investment fund of Sp-Rahastoyhtiö, in Bioretec's shares and votes has exceeded 5 per cent on 29 April 2026.

The total number of shares and votes in Bioretec is 1,341,785,963.

Bioretec has one series of shares in which each share carries one vote.

The total holding of the notifier in Bioretec's shares and votes according to the notification:

                                                                            % of shares and % of shares and voting rights   Total of Total number of shares and
                                                                             voting rights   through financial instruments both in %  voting rights of issuer



 Resulting situation on the date on which threshold was crossed or reached          8.01 %                                   8.01 %              1,341,785,963



 Position of previous notification (if applicable)

Notified details of the resulting situation on the date on which the threshold was crossed or reached:

A: Shares and voting rights

                         Number of shares and voting             % of shares and voting
                                    rights                               rights


 Class /type
  of shares              Direct              Indirect           Direct              Indirect
              (SMA 9:5)            (SMA 9:6 and       (SMA 9:5)           (SMA 9:6 and
                                   9:7)                                   9:7)


 FI4000480454       107,531,243                                  8.01 %


 SUBTOTAL A         107,531,243                                  8.01 %

Contacts

Sarah van Hellenberg Hubar-Fisher, CEO, +31 6 1544 8736
Tuukka Paavola, CFO, +358 50 386 0013

Information about Bioretec

Bioretec is a globally operating Finnish medical device pioneer at the forefront of transforming orthopedic care with fully biodegradable implant technologies. The company has built unique competencies in the biological interface of active implants to enhance bone growth and accelerate fracture healing after orthopedic surgery. The products developed and manufactured by Bioretec are used worldwide in approximately 40 countries.

The company's latest innovation, the RemeOs™ product line, is based on a high-performance magnesium alloy and hybrid composite, introducing a new generation of strong absorbable materials for enhanced surgical outcomes. The RemeOs implants are absorbed and replaced by bone, which eliminates the need for removal surgery while facilitating fracture healing. The first RemeOs product market authorization was received in the U.S. in March 2023, and in Europe, the CE mark approval was received in January 2025.

Bioretec's Activa product line features fully bioabsorbable orthopedic implants made from a proprietary, self-reinforced PLGA both CE marked and FDA cleared for a wide range of indications in adult and pediatric patients.

Bioretec is shaping the future of orthopedic treatment with a focus on healing through absorption, paving the way for more effective and patient-friendly solutions.

To learn more about Bioretec, visit www.bioretec.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/bioretec/r/bioretec-ltd--notification-pursuant-to-chapter-9--section-10-of-the-finnish-securities-markets-act--,c4342352

View original content:https://www.prnewswire.co.uk/news-releases/bioretec-ltd-notification-pursuant-to-chapter-9-section-10-of-the-finnish-securities-markets-act-sp-rahastoyhtio-302757367.html

Tags

More Like This

Bioretec Ltd: Notification pursuant to Chapter 9, Section 10 of the Finnish Securities Markets Act (Kustaa Poutiainen)

Bioretec Ltd: Notification in accordance with chapter 9, section 10 of the Securities Market Act on a change in holdings (W&M GmbH)

New shares of Bioretec Ltd registered with the trade register

Bioretec Ltd adjusts the terms and conditions of its stock option programs due to the completed rights issue

Bioretec Ltd's resolutions of the constitutive meeting of the Board of Directors

Bioretec Ltd - Managers' transactions

Bioretec Ltd - Manager's transactions - Paavola

Bioretec Ltd - Manager's transactions - Stephen Industries Inc Oy